Arkema S.A. (OTCMKTS:ARKAY - Get Free Report)'s stock price passed below its two hundred day moving average during trading on Tuesday . The stock has a two hundred day moving average of $79.62 and traded as low as $73.25. Arkema shares last traded at $74.20, with a volume of 22,179 shares trading hands.
Wall Street Analysts Forecast Growth
Separately, Sanford C. Bernstein assumed coverage on shares of Arkema in a report on Thursday, April 24th. They set an "underperform" rating on the stock.
Get Our Latest Analysis on ARKAY
Arkema Stock Up 1.0%
The firm has a 50-day moving average of $77.22 and a two-hundred day moving average of $79.24. The company has a current ratio of 2.11, a quick ratio of 1.54 and a debt-to-equity ratio of 0.48. The firm has a market capitalization of $5.65 billion, a PE ratio of 14.86, a price-to-earnings-growth ratio of 0.53 and a beta of 1.11.
Arkema (OTCMKTS:ARKAY - Get Free Report) last issued its earnings results on Wednesday, May 7th. The basic materials company reported $1.37 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $1.45 by ($0.08). The business had revenue of $2.70 billion during the quarter, compared to the consensus estimate of $2.44 billion. Arkema had a return on equity of 8.04% and a net margin of 3.82%. On average, equities research analysts forecast that Arkema S.A. will post 8.36 EPS for the current year.
Arkema Company Profile
(
Get Free Report)
Arkema SA manufactures and sells specialty chemicals and advanced materials worldwide. The company operates in three segments: Adhesive Solutions, Advanced Materials and Coating Solutions, and Intermediates. The Adhesive Solutions segment provides solutions for construction, renovation of buildings, DIY, durable goods, and packaging and non-woven applications; and supplies technologies used in building activities for businesses and individuals, including sealants, tiles, flooring adhesives and waterproofing systems, and technologies used in industry, which include automotive, textiles, glazing, flexible and rigid packaging, and hygiene markets.
Read More
Before you consider Arkema, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Arkema wasn't on the list.
While Arkema currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
